Cite

HARVARD Citation

    Mulleman, D. et al. (2018). Adalimumab concentration-based tapering strategy: as good as the recommended dosage. Annals of the rheumatic diseases. 77 (4), pp. 473-475. [Online]. 
  
Back to record